Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9.

Commisso B, Ding L, Varadi K, Gorges M, Bayer D, Boeckers TM, Ludolph AC, Kassubek J, Müller OJ, Roselli F.

Elife. 2018 Aug 23;7. pii: e36892. doi: 10.7554/eLife.36892.

2.

Parvalbumin Interneurons Shape Neuronal Vulnerability in Blunt TBI.

Chandrasekar A, Olde Heuvel F, Tar L, Hagenston AM, Palmer A, Linkus B, Ludolph AC, Huber-Lang M, Boeckers T, Bading H, Roselli F.

Cereb Cortex. 2018 Jun 30. doi: 10.1093/cercor/bhy139. [Epub ahead of print]

PMID:
29982364
3.

Nutrient limitation affects presynaptic structures through dissociable Bassoon autophagic degradation and impaired vesicle release.

Catanese A, Garrido D, Walther P, Roselli F, Boeckers TM.

J Cereb Blood Flow Metab. 2018 Nov;38(11):1924-1939. doi: 10.1177/0271678X18786356. Epub 2018 Jul 4.

PMID:
29972341
4.

Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application.

Roselli F, Chandrasekar A, Morganti-Kossmann MC.

Front Neurol. 2018 Jun 19;9:458. doi: 10.3389/fneur.2018.00458. eCollection 2018. Review.

5.

NF-κB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS.

Ouali Alami N, Schurr C, Olde Heuvel F, Tang L, Li Q, Tasdogan A, Kimbara A, Nettekoven M, Ottaviani G, Raposo C, Röver S, Rogers-Evans M, Rothenhäusler B, Ullmer C, Fingerle J, Grether U, Knuesel I, Boeckers TM, Ludolph A, Wirth T, Roselli F, Baumann B.

EMBO J. 2018 Aug 15;37(16). pii: e98697. doi: 10.15252/embj.201798697. Epub 2018 Jun 6.

6.

The Neuroprotective Effect of Ethanol Intoxication in Traumatic Brain Injury Is Associated with the Suppression of ErbB Signaling in Parvalbumin-Positive Interneurons.

Chandrasekar A, Olde Heuvel F, Wepler M, Rehman R, Palmer A, Catanese A, Linkus B, Ludolph A, Boeckers T, Huber-Lang M, Radermacher P, Roselli F.

J Neurotrauma. 2018 Nov 15;35(22):2718-2735. doi: 10.1089/neu.2017.5270. Epub 2018 Jul 23.

PMID:
29774782
7.

Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS.

Martínez-Silva ML, Imhoff-Manuel RD, Sharma A, Heckman CJ, Shneider NA, Roselli F, Zytnicki D, Manuel M.

Elife. 2018 Mar 27;7. pii: e30955. doi: 10.7554/eLife.30955.

8.

Neuroinflammation after Traumatic Brain Injury Is Enhanced in Activating Transcription Factor 3 Mutant Mice.

Förstner P, Rehman R, Anastasiadou S, Haffner-Luntzer M, Sinske D, Ignatius A, Roselli F, Knöll B.

J Neurotrauma. 2018 Oct 1;35(19):2317-2329. doi: 10.1089/neu.2017.5593. Epub 2018 Jun 5.

PMID:
29463176
9.

Neuroprotective effect of acute ethanol intoxication in TBI is associated to the hierarchical modulation of early transcriptional responses.

Chandrasekar A, Aksan B, Heuvel FO, Förstner P, Sinske D, Rehman R, Palmer A, Ludolph A, Huber-Lang M, Böckers T, Mauceri D, Knöll B, Roselli F.

Exp Neurol. 2018 Apr;302:34-45. doi: 10.1016/j.expneurol.2017.12.017. Epub 2018 Jan 4.

PMID:
29306704
10.

Reversible induction of TDP-43 granules in cortical neurons after traumatic injury.

Wiesner D, Tar L, Linkus B, Chandrasekar A, Olde Heuvel F, Dupuis L, Tsao W, Wong PC, Ludolph A, Roselli F.

Exp Neurol. 2018 Jan;299(Pt A):15-25. doi: 10.1016/j.expneurol.2017.09.011. Epub 2017 Sep 21.

PMID:
28941811
11.

Medusa's Head: The Complement System in Traumatic Brain and Spinal Cord Injury.

Roselli F, Karasu E, Volpe C, Huber-Lang M.

J Neurotrauma. 2018 Jan 15;35(2):226-240. doi: 10.1089/neu.2017.5168. Epub 2017 Nov 10.

PMID:
28816089
12.

Acute ethanol administration results in a protective cytokine and neuroinflammatory profile in traumatic brain injury.

Chandrasekar A, Heuvel FO, Palmer A, Linkus B, Ludolph AC, Boeckers TM, Relja B, Huber-Lang M, Roselli F.

Int Immunopharmacol. 2017 Oct;51:66-75. doi: 10.1016/j.intimp.2017.08.002. Epub 2017 Aug 12.

PMID:
28806641
13.

Functional Connectivity Mapping in the Animal Model: Principles and Applications of Resting-State fMRI.

Gorges M, Roselli F, Müller HP, Ludolph AC, Rasche V, Kassubek J.

Front Neurol. 2017 May 10;8:200. doi: 10.3389/fneur.2017.00200. eCollection 2017. Review.

14.

Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.

Li Y, Chang L, Song Y, Gao X, Roselli F, Liu J, Zhou W, Fang Y, Ling W, Li H, Almeida OF, Wu Y.

J Alzheimers Dis. 2016 Aug 1;54(1):135-48. doi: 10.3233/JAD-160297.

PMID:
27497478
15.

From the editors.

Pedersen AE, Satoh M, Marriott I, Roselli F.

Immunopharmacol Immunotoxicol. 2016;38(1):1. doi: 10.3109/08923973.2015.1127509. No abstract available.

PMID:
26849901
16.

From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases.

Roselli F, Caroni P.

Neuron. 2015 Mar 4;85(5):901-10. doi: 10.1016/j.neuron.2014.12.063. Review.

17.

Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition.

Vogl AM, Brockmann MM, Giusti SA, Maccarrone G, Vercelli CA, Bauder CA, Richter JS, Roselli F, Hafner AS, Dedic N, Wotjak CT, Vogt-Weisenhorn DM, Choquet D, Turck CW, Stein V, Deussing JM, Refojo D.

Nat Neurosci. 2015 Feb;18(2):239-51. doi: 10.1038/nn.3912. Epub 2015 Jan 12.

PMID:
25581363
18.

Modeling neuronal vulnerability in ALS.

Roselli F, Caroni P.

Neuron. 2014 Aug 20;83(4):758-60. doi: 10.1016/j.neuron.2014.08.010.

19.

Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.

Saxena S, Roselli F, Singh K, Leptien K, Julien JP, Gros-Louis F, Caroni P.

Neuron. 2013 Oct 2;80(1):80-96. doi: 10.1016/j.neuron.2013.07.027. Epub 2013 Oct 2.

20.

Non-receptor-tyrosine kinases integrate fast glucocorticoid signaling in hippocampal neurons.

Yang S, Roselli F, Patchev AV, Yu S, Almeida OF.

J Biol Chem. 2013 Aug 16;288(33):23725-39. doi: 10.1074/jbc.M113.470146. Epub 2013 Jul 1.

21.

β-Site amyloid precursor protein-cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau.

Tsolakidou A, Alexopoulos P, Guo LH, Grimmer T, Westerteicher C, Kratzer M, Jiang M, Bujo H, Roselli F, Leante MR, Livrea P, Kurz A, Perneczky R.

Alzheimers Dement. 2013 Jul;9(4):386-91. doi: 10.1016/j.jalz.2012.01.015. Epub 2012 Nov 3.

PMID:
23127467
22.

A circuit mechanism for neurodegeneration.

Roselli F, Caroni P.

Cell. 2012 Oct 12;151(2):250-2. doi: 10.1016/j.cell.2012.09.030.

23.

Down syndrome DSCR1 causes spine pathology via the Fragile X-related protein FMRP.

Roselli F.

EMBO J. 2012 Sep 12;31(18):3647-9. doi: 10.1038/emboj.2012.239. Epub 2012 Aug 21. No abstract available.

24.

Life-or-death decisions upon axonal damage.

Roselli F, Caroni P.

Neuron. 2012 Feb 9;73(3):405-7. doi: 10.1016/j.neuron.2012.01.009.

25.

Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid.

Alexopoulos P, Tsolakidou A, Roselli F, Arnold A, Grimmer T, Westerteicher C, Leante MR, Förstl H, Livrea P, Kurz A, Perneczky R.

Alzheimers Dement. 2012 Jul;8(4):304-11. doi: 10.1016/j.jalz.2011.04.009. Epub 2011 Nov 4.

PMID:
22055653
26.

CDK5 is essential for soluble amyloid β-induced degradation of GKAP and remodeling of the synaptic actin cytoskeleton.

Roselli F, Livrea P, Almeida OF.

PLoS One. 2011;6(7):e23097. doi: 10.1371/journal.pone.0023097. Epub 2011 Jul 29.

27.

Amyloid-β induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors.

Liu J, Chang L, Roselli F, Almeida OF, Gao X, Wang X, Yew DT, Wu Y.

J Alzheimers Dis. 2010;22(2):541-56. doi: 10.3233/JAD-2010-100948.

PMID:
20847396
28.

Brain F-18 Fluorocholine PET/CT for the assessment of optic pathway glioma in neurofibromatosis-1.

Roselli F, Pisciotta NM, Aniello MS, Niccoli-Asabella A, Defazio G, Livrea P, Rubini G.

Clin Nucl Med. 2010 Oct;35(10):838-9. doi: 10.1097/RLU.0b013e3181ef0b45.

PMID:
20838306
29.

Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study.

Roselli F, Pisciotta NM, Pennelli M, Aniello MS, Gigante A, De Caro MF, Ferrannini E, Tartaglione B, Niccoli-Asabella A, Defazio G, Livrea P, Rubini G.

Mov Disord. 2010 Sep 15;25(12):1853-9. doi: 10.1002/mds.23179. Erratum in: Mov Disord. 2010 Oct 30;25(14):2478.

PMID:
20669272
30.

Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

Roselli F, Pisciotta NM, Perneczky R, Pennelli M, Aniello MS, De Caro MF, Ferrannini E, Tartaglione B, Defazio G, Rubini G, Livrea P.

Mov Disord. 2009 Oct 30;24(14):2097-103. doi: 10.1002/mds.22702.

PMID:
19705471
31.

Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways.

Roselli F, Hutzler P, Wegerich Y, Livrea P, Almeida OF.

PLoS One. 2009 Jun 23;4(6):e6011. doi: 10.1371/journal.pone.0006011.

32.

Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia.

Martino D, Muglia M, Abbruzzese G, Berardelli A, Girlanda P, Liguori M, Livrea P, Quattrone A, Roselli F, Sprovieri T, Valente EM, Defazio G.

Eur J Neurol. 2009 Aug;16(8):949-52. doi: 10.1111/j.1468-1331.2009.02633.x. Epub 2009 Apr 17.

PMID:
19473353
33.

Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors.

Roselli F, Tartaglione B, Federico F, Lepore V, Defazio G, Livrea P.

Clin Neurol Neurosurg. 2009 May;111(4):327-30. doi: 10.1016/j.clineuro.2008.10.006. Epub 2008 Nov 25.

PMID:
19036496
34.

Voltage-gated sodium channel blockers as immunomodulators.

Roselli F, Livrea P, Jirillo E.

Recent Pat CNS Drug Discov. 2006 Jan;1(1):83-91. Review.

PMID:
18221194
35.

Holmes' tremor associated to HSV-1 cerebral pedunculitis: a case report.

Roselli F, Livrea P, Defazio G, Manobianca G, Ardito B, Gentile MA, Pisciotta MN, Rubini G.

Mov Disord. 2007 Jun 15;22(8):1204-6. No abstract available.

PMID:
17486642
36.

Reversible Parkinsonian syndrome associated with anti-neuronal antibodies in acute EBV encephalitis: a case report.

Roselli F, Russo I, Fraddosio A, Aniello MS, De Mari M, Lamberti P, Livrea P, Defazio G.

Parkinsonism Relat Disord. 2006 May;12(4):257-60. Epub 2006 Feb 3.

PMID:
16459123
37.

Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.

Roselli F, Tirard M, Lu J, Hutzler P, Lamberti P, Livrea P, Morabito M, Almeida OF.

J Neurosci. 2005 Nov 30;25(48):11061-70.

38.

Hypertrophy of inferior turbinates: radiofrequency surgery.

Bruno E, D'Erme G, Roselli F, Alessandrini M.

An Otorrinolaringol Ibero Am. 2003;30(5):439-46.

PMID:
14648924
39.

Blepharospasm in bardet-biedl syndrome: a case report.

Roselli F, De Tommaso M, Stella Aniello M, Livrea P, Defazio G.

Eur Neurol. 2002;48(4):230-2. No abstract available.

PMID:
12422076
40.

Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.

Defazio G, Abbruzzese G, Girlanda P, Vacca L, Currà A, De Salvia R, Marchese R, Raineri R, Roselli F, Livrea P, Berardelli A.

Arch Neurol. 2002 Mar;59(3):418-20.

PMID:
11890846
41.

Interferon beta-1a downregulates TNFalpha-induced intercellular adhesion molecule 1 expression on brain microvascular endothelial cells through a tyrosine kinase-dependent pathway.

Defazio G, Livrea P, Giorelli M, Martino D, Roselli F, Ricchiuti F, Trojano M.

Brain Res. 2000 Oct 27;881(2):227-30.

PMID:
11036165

Supplemental Content

Loading ...
Support Center